Non-antibiotic antibacterial peptides and proteins ofEscherichia coli: efficacy and potency of bacteriocins

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F21%3A00120740" target="_blank" >RIV/00216224:14110/21:00120740 - isvavai.cz</a>

Výsledek na webu

<a href="https://www.tandfonline.com/doi/full/10.1080/14787210.2020.1816824" target="_blank" >https://www.tandfonline.com/doi/full/10.1080/14787210.2020.1816824</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1080/14787210.2020.1816824" target="_blank" >10.1080/14787210.2020.1816824</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Non-antibiotic antibacterial peptides and proteins ofEscherichia coli: efficacy and potency of bacteriocins

Popis výsledku v původním jazyce

Introduction The emergence and spread of antibiotic resistance among pathogenic bacteria drives the search for alternative antimicrobial therapies. Bacteriocins represent a potential alternative to antibiotic treatment. In contrast to antibiotics, bacteriocins are peptides or proteins that have relatively narrow spectra of antibacterial activities and are produced by a wide range of bacterial species. Bacteriocins ofEscherichia coliare historically classified as microcins and colicins, and, until now, more than 30 different bacteriocin types have been identified and characterized. Areas covered We performed bibliographical searches of online databases to review the literature regarding bacteriocins produced byE. coliwith respect to their occurrence, bacteriocin role in bacterial colonization and pathogenicity, and application of their antimicrobial effect. Expert opinion The potential use of bacteriocins for applications in human and animal medicine and the food industry includes (i) the use of bacteriocin-producing probiotic strains, (ii) recombinant production in plants and application in food, and (iii) application of purified bacteriocins.

Název v anglickém jazyce

Non-antibiotic antibacterial peptides and proteins ofEscherichia coli: efficacy and potency of bacteriocins

Popis výsledku anglicky

Introduction The emergence and spread of antibiotic resistance among pathogenic bacteria drives the search for alternative antimicrobial therapies. Bacteriocins represent a potential alternative to antibiotic treatment. In contrast to antibiotics, bacteriocins are peptides or proteins that have relatively narrow spectra of antibacterial activities and are produced by a wide range of bacterial species. Bacteriocins ofEscherichia coliare historically classified as microcins and colicins, and, until now, more than 30 different bacteriocin types have been identified and characterized. Areas covered We performed bibliographical searches of online databases to review the literature regarding bacteriocins produced byE. coliwith respect to their occurrence, bacteriocin role in bacterial colonization and pathogenicity, and application of their antimicrobial effect. Expert opinion The potential use of bacteriocins for applications in human and animal medicine and the food industry includes (i) the use of bacteriocin-producing probiotic strains, (ii) recombinant production in plants and application in food, and (iii) application of purified bacteriocins.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

10606 - Microbiology

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY

ISSN

1478-7210

e-ISSN

1744-8336

Svazek periodika

19

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

14

Strana od-do

309-322

Kód UT WoS článku

000571964600001

EID výsledku v databázi Scopus

2-s2.0-85091319830